“…In contrast to PET/SPECT, XFI allows external control over radiation exposure, variable size scales (from variable resolution and beam positioning), and nondecaying substances, such as those based on nanoparticles (NPs). This enables serial, longitudinal, multiplexed, and targeted imaging at lower radiation doses [9,10,15,[18][19][20][21]. Furthermore, XFI exhibits superior spatial resolution and depth of tissue penetration compared to current optical imaging methods while achieving resolution on par with computed tomography (CT) and MRI [9,13,15,[17][18][19].…”